The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

   |<   1/2   << Previous Page   Page 61   Next Page >>   1/2   >|       Skip To

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN Lymphoedema 2
SANDOSTATIN Macular degeneration 2
SANDOSTATIN Malaria 2
SANDOSTATIN Malnutrition 2
SANDOSTATIN Mass 2
SANDOSTATIN Melanocytic naevus 2
SANDOSTATIN Mental disorder 2
SANDOSTATIN Mental impairment 2
SANDOSTATIN Metastases to bone 2
SANDOSTATIN Metastases to breast 2
SANDOSTATIN Mood swings 2
SANDOSTATIN Muscle tightness 2
SANDOSTATIN Musculoskeletal chest pain 2
SANDOSTATIN Musculoskeletal stiffness 2
SANDOSTATIN Neck mass 2
SANDOSTATIN Nerve compression 2
SANDOSTATIN Neuroendocrine tumour 2
SANDOSTATIN Night sweats 2
SANDOSTATIN No adverse event 2
SANDOSTATIN Oesophageal spasm 2

   |<   1/2   << Previous Page   Page 61   Next Page >>   1/2   >|       Skip To

Total Records: 2,045     Number of Pages: 103

Execution Time: 0.17498087882996 seconds (ucode:6755654). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and Global Public Data.